| MLEC | Moolec Science SA | 0.01 | -99.82% |
| LSB | LakeShore Biopharma Co Ltd | 0.02 | -99.56% |
| ENVB | Enveric Biosciences Inc | 0.08 | -98.45% |
| CASI | CASI Pharmaceuticals Inc | 0.12 | -97.65% |
| KPRX | Kiora Pharmaceuticals Inc | 0.14 | -97.19% |
| JAGX | Jaguar Health Inc | 0.30 | -94.05% |
| LITS | Lite Strategy Inc | 0.31 | -93.88% |
| AFMD | Affimed N.V. | 0.53 | -89.68% |
| HRTX | Heron Therapeutics Inc | 0.54 | -89.45% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.58 | -88.74% |
| ENSC | Ensysce Biosciences Inc | 0.61 | -88.06% |
| FTRE | Fortrea Holdings Inc | 0.63 | -87.79% |
| CLSD | Clearside Biomedical, Inc. Common Stock | 0.64 | -87.40% |
| ONCT | Oncternal Therapeutics Inc | 0.72 | -85.90% |
| CELU | Celularity Inc - Class A | 0.85 | -83.39% |
| SRPT | Sarepta Therapeutics Inc | 0.87 | -83.04% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.97 | -81.04% |
| GOSS | Gossamer Bio Inc | 0.98 | -80.93% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 1.12 | -78.14% |
| XLO | Xilio Therapeutics Inc | 1.14 | -77.80% |
| PTN | Palatin Technologies Inc | 1.22 | -76.12% |
| BOLT | Bolt Biotherapeutics Inc | 1.25 | -75.67% |
| FBIOP | Fortress Biotech Inc | 1.25 | -75.62% |
| HCWB | HCW Biologics Inc | 1.25 | -75.59% |
| CRIS | Curis Inc | 1.30 | -74.50% |
| IMRN | Immuron Ltd | 1.34 | -73.83% |
| CSBR | Champions Oncology Inc | 1.36 | -73.50% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | 1.39 | -72.74% |
| RVNC | Revance Therapeutics Inc | 1.48 | -71.07% |
| KPTI | Karyopharm Therapeutics Inc | 1.50 | -70.66% |
| AVIR | Atea Pharmaceuticals Inc | 1.55 | -69.65% |
| MDXG | Mimedx Group Inc | 1.61 | -68.61% |
| SPRO | Spero Therapeutics Inc | 1.61 | -68.55% |
| VNDA | Vanda Pharmaceuticals Inc | 1.61 | -68.44% |
| CRMD | CorMedix Inc | 1.62 | -68.30% |
| NEUP | Neuphoria Therapeutics Inc | 1.70 | -66.76% |
| AGEN | Agenus Inc | 1.71 | -66.62% |
| MGNX | Macrogenics Inc | 1.74 | -66.07% |
| GLPG | Galapagos NV | 1.74 | -65.99% |
| SVA | Sinovac Biotech Ltd | 1.83 | -64.22% |
| PBYI | Puma Biotechnology Inc | 1.85 | -63.75% |
| NERV | Minerva Neurosciences Inc | 1.87 | -63.49% |
| FBIO | Fortress Biotech Inc | 1.87 | -63.39% |
| THTX | Theratechnologies Inc | 1.98 | -61.24% |
| BDTX | Black Diamond Therapeutics Inc | 2.11 | -58.72% |
| NAGE | Niagen Bioscience Inc | 2.12 | -58.59% |
| XBIO | Xenetic Biosciences Inc | 2.15 | -57.88% |
| RADX | Radiopharm Theranostics Ltd | 2.22 | -56.65% |
| MGX | Metagenomi Inc | 2.23 | -56.52% |
| HRMY | Harmony Biosciences Holdings Inc | 2.25 | -56.09% |
| NVAX | Novavax Inc | 2.32 | -54.62% |
| SPRC | SciSparc Ltd | 2.33 | -54.42% |
| GNFT | GENFIT S.A. American Depositary Shares | 2.44 | -52.38% |
| PLX | Protalix BioTherapeutics Inc | 2.44 | -52.37% |
| CDXS | Codexis Inc | 2.48 | -51.55% |
| SAVA | Cassava Sciences Inc. | 2.54 | -50.42% |
| RIGL | Rigel Pharmaceuticals | 2.54 | -50.34% |
| PHAR | Pharming Group N.V. | 2.55 | -50.09% |
| CTXR | Citius Pharmaceuticals Inc | 2.60 | -49.13% |
| VRCA | Verrica Pharmaceuticals Inc | 2.62 | -48.87% |
| FULC | Fulcrum Therapeutics Inc | 2.66 | -48.07% |
| APVO | Aptevo Therapeutics Inc | 2.70 | -47.15% |
| REVB | Revelation Biosciences Inc | 2.88 | -43.67% |
| SABS | SAB Biotherapeutics Inc | 2.96 | -42.17% |
| ARDX | Ardelyx Inc | 2.98 | -41.76% |
| CGEN | Compugen Ltd | 2.99 | -41.49% |
| VERU | Veru Inc | 3.11 | -39.22% |
| ATRA | Atara Biotherapeutics Inc | 3.13 | -38.81% |
| SXTP | 60 Degrees Pharmaceuticals Inc | 3.13 | -38.73% |
| EVGN | Evogene Ltd | 3.17 | -38.03% |
| ICCC | Immucell Corp | 3.24 | -36.62% |
| BGMS | Bio Green Med Solution Inc | 3.28 | -35.96% |
| AAPG | Ascentage Pharma Group International | 3.28 | -35.88% |
| MNKD | Mannkind Corp | 3.32 | -35.06% |
| VALN | Valneva SE | 3.35 | -34.57% |
| ARCT | Arcturus Therapeutics Holdings Inc | 3.36 | -34.31% |
| JAZZ | Jazz Pharmaceuticals plc | 3.37 | -34.16% |
| EVAX | Evaxion Biotech A/S | 3.38 | -33.96% |
| PTHS | Channel Therapeutics Corporation | 3.41 | -33.30% |
| BMRN | Biomarin Pharmaceutical Inc | 3.50 | -31.68% |
| BCAB | BioAtla Inc | 3.54 | -30.91% |
| SLDB | Solid Biosciences Inc | 3.65 | -28.76% |
| CUE | Cue Biopharma Inc | 3.66 | -28.55% |
| IPSC | Century Therapeutics Inc | 3.72 | -27.36% |
| BRNS | Barinthus Biotherapeutics Plc. | 3.80 | -25.75% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 3.81 | -25.62% |
| INVA | Innoviva Inc | 3.81 | -25.46% |
| CLLS | Cellectis | 3.85 | -24.68% |
| LEGN | Legend Biotech Corp | 3.91 | -23.53% |
| ONCO | Onconetix Inc | 3.92 | -23.29% |
| ACAD | Acadia Pharmaceuticals Inc | 3.98 | -22.12% |
| ADMA | Adma Biologics Inc | 4.03 | -21.20% |
| IMCR | Immunocore Holdings plc | 4.27 | -16.49% |
| INCY | Incyte Corp | 4.28 | -16.33% |
| PHAT | Phathom Pharmaceuticals Inc | 4.30 | -15.94% |
| IVVD | Invivyd Inc | 4.31 | -15.81% |
| STRO | Sutro Biopharma Inc | 4.33 | -15.47% |
| GERN | Geron Corp | 4.51 | -11.78% |
| YMAB | Y-Mabs Therapeutics Inc | 4.57 | -10.69% |
| GMAB | Genmab | 4.58 | -10.55% |
| BCYC | Bicycle Therapeutics Plc | 4.64 | -9.32% |
| TARS | Tarsus Pharmaceuticals Inc | 4.69 | -8.36% |
| RARE | Ultragenyx Pharmaceutical Inc | 4.71 | -7.99% |
| ABUS | Arbutus Biopharma Corp | 4.76 | -7.03% |
| TLX | Telix Pharmaceuticals Ltd | 4.76 | -7.01% |
| APLM | Apollomics Inc - Class A | 4.77 | -6.85% |
| REGN | Regeneron Pharmaceuticals Inc | 4.77 | -6.76% |
| CHRS | Coherus Biosciences Inc | 4.77 | -6.76% |
| TRAW | Traws Pharma Inc | 4.77 | -6.72% |
| QTTB | Q32 Bio Inc | 4.95 | -3.18% |
| ZLAB | Zai Lab Ltd | 4.96 | -2.97% |
| DTIL | Precision Biosciences Inc | 5.04 | -1.50% |
| ACHV | Achieve Life Sciences Inc | 5.09 | -0.52% |
| VYGR | Voyager Therapeutics Inc | 5.23 | +2.21% |
| ELAB | PMGC Holdings Inc | 5.26 | +2.83% |
| PSTV | Plus Therapeutics Inc | 5.42 | +5.93% |
| CAI | Caris Life Sciences Inc - Class A | 5.44 | +6.32% |
| ENTA | Enanta Pharmaceuticals Inc | 5.51 | +7.69% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 5.61 | +9.64% |
| ONC | BeiGene Ltd | 5.63 | +10.03% |
| RNA | Atrium Therapeutics Inc | 5.70 | +11.40% |
| EXEL | Exelixis Inc | 5.89 | +15.11% |
| HALO | Halozyme Therapeutics Inc | 5.90 | +15.31% |
| ARVN | Arvinas Inc | 5.98 | +16.87% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 6.02 | +17.57% |
| GYRE | Gyre Therapeutics Inc | 6.04 | +18.04% |
| SCPH | scPharmaceuticals Inc | 6.10 | +19.13% |
| IOVA | Iovance Biotherapeutics Inc | 6.14 | +20.00% |
| ZVRA | Zevra Therapeutics Inc | 6.26 | +22.34% |
| CPRX | Catalyst Pharmaceuticals Inc | 6.46 | +26.25% |
| KROS | Keros Therapeutics Inc | 6.58 | +28.60% |
| MRKR | Marker Therapeutics Inc | 6.63 | +29.57% |
| OBIO | Orchestra BioMed Holdings Inc | 6.68 | +30.55% |
| AUPH | Aurinia Pharmaceuticals Inc | 6.89 | +34.66% |
| ANAB | AnaptysBio Inc | 6.90 | +34.85% |
| FDMT | 4D Molecular Therapeutics Inc | 6.92 | +35.24% |
| ZNTL | Zentalis Pharmaceuticals Inc | 7.13 | +39.35% |
| TCRX | Tscan Therapeutics Inc | 7.14 | +39.48% |
| RGNX | Regenxbio Inc | 7.23 | +41.30% |
| LENZ | LENZ Therapeutics Inc | 7.45 | +45.60% |
| ASMB | Assembly Biosciences Inc | 7.46 | +45.80% |
| SPRY | ARS Pharmaceuticals Inc | 7.57 | +47.95% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 7.58 | +48.06% |
| ALGS | Aligos Therapeutics Inc | 7.59 | +48.34% |
| FENC | Fennec Pharmaceuticals Inc | 7.60 | +48.53% |
| PRTA | Prothena Corporation plc | 7.62 | +48.92% |
| NTBL | Notable Labs Inc Ord | 7.65 | +49.51% |
| SEER | Seer Inc - Class A | 7.83 | +53.03% |
| PTCT | PTC Therapeutics Inc | 7.83 | +53.03% |
| VTGN | VistaGen Therapeutics Inc | 7.96 | +55.57% |
| TBPH | Theravance Biopharma Inc | 7.99 | +56.15% |
| CYCN | Cyclerion Therapeutics Inc | 8.06 | +57.52% |
| VCEL | Vericel Corp | 8.06 | +57.52% |
| ARTV | Artiva Biotherapeutics Inc | 8.11 | +58.50% |
| IMMP | Immutep Ltd | 8.12 | +58.70% |
| BNTX | BioNTech SE | 8.29 | +62.02% |
| ARQT | Arcutis Biotherapeutics Inc | 8.36 | +63.39% |
| IONS | Ionis Pharmaceuticals Inc | 8.58 | +67.69% |
| ALNY | Alnylam Pharmaceuticals Inc | 8.76 | +71.20% |
| ALEC | Alector Inc | 9.04 | +76.68% |
| GOVX | Geovax Labs Inc | 9.09 | +77.65% |
| TECH | Bio-Techne Corp | 9.17 | +79.22% |
| LPCN | Lipocine Inc | 9.51 | +85.86% |
| NXTC | Nextcure Inc | 9.52 | +86.06% |
| BLRX | Bioline Rx Ltd | 9.56 | +86.84% |
| ACET | Adicet Bio Inc | 9.72 | +89.97% |
| SNGX | Soligenix Inc | 9.78 | +91.14% |
| TVTX | Travere Therapeutics Inc | 9.84 | +92.31% |
| SNDX | Syndax Pharmaceuticals Inc | 9.85 | +92.51% |
| VSTM | Verastem Inc | 9.87 | +92.90% |
| VRTX | Vertex Pharmaceuticals Inc | 9.89 | +93.29% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 10.04 | +96.22% |
| HOWL | Werewolf Therapeutics Inc | 10.21 | +99.54% |
| IKT | Inhibikase Therapeutics Inc | 10.39 | +103.06% |
| OABI | OmniAb Inc | 10.42 | +103.65% |
| PYXS | Pyxis Oncology Inc | 10.69 | +108.92% |
| MDGL | Madrigal Pharmaceuticals Inc | 10.93 | +113.61% |
| CTNM | Contineum Therapeutics Inc - Class A | 11.15 | +117.91% |
| ARGX | Argen X SE | 11.27 | +120.26% |
| FHTX | Foghorn Therapeutics Inc | 11.34 | +121.63% |
| XNCR | Xencor Inc | 11.41 | +122.99% |
| DYAI | Dyadic International Inc DE | 11.58 | +126.32% |
| PALI | Palisade Bio Inc | 11.78 | +130.23% |
| CCCC | C4 Therapeutics Inc | 11.93 | +133.16% |
| TGTX | TG Therapeutics Inc | 12.00 | +134.52% |
| MRNA | Moderna Inc | 12.18 | +138.04% |
| XBIT | XBiotech Inc | 12.23 | +139.02% |
| CORT | Corcept Therapeutics Inc | 12.63 | +146.84% |
| MDWD | MediWound Ltd | 12.65 | +147.23% |
| ICU | SeaStar Medical Holding Corp | 12.86 | +151.33% |
| MIRM | Mirum Pharmaceuticals Inc | 12.95 | +153.09% |
| SRRK | Scholar Rock Holding Corp | 13.14 | +156.80% |
| RPRX | Royalty Pharma plc - Class A | 13.14 | +156.80% |
| URGN | UroGen Pharma Ltd | 13.37 | +161.30% |
| LXRX | Lexicon Pharmaceuticals Inc | 13.52 | +164.23% |
| ANL | Adlai Nortye Ltd | 13.52 | +164.31% |
| ATHE | Alterity Therapeutics Ltd | 13.60 | +165.79% |
| XCUR | Exicure Inc | 13.61 | +165.99% |
| CRVO | CervoMed Inc | 13.61 | +165.99% |
| SLGL | Sol-Gel Technologies Ltd | 13.67 | +167.16% |
| EDIT | Editas Medicine Inc | 13.68 | +167.36% |
| KURA | Kura Oncology Inc | 13.93 | +172.24% |
| GDTC | CytoMed Therapeutics Ltd | 14.02 | +174.00% |
| COYA | Coya Therapeutics Inc | 14.30 | +179.48% |
| NUVB | Nuvation Bio Inc - Class A | 14.36 | +180.65% |
| MGTX | MeiraGTx Holdings plc | 14.58 | +184.95% |
| XOMA | XOMA Royalty Corp | 14.63 | +185.92% |
| CVAC | CureVac N.V. | 14.83 | +189.83% |
| APLT | Applied Therapeutics Inc | 14.86 | +190.42% |
| RCUS | Arcus Biosciences Inc | 14.93 | +191.79% |
| CRBU | Caribou Biosciences Inc | 15.32 | +199.41% |
| IDYA | Ideaya Biosciences Inc | 15.70 | +206.84% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.28 | +218.17% |
| WVE | Wave Life Sciences Ltd | 16.43 | +221.10% |
| CLGN | CollPlant Biotechnologies Ltd New | 16.50 | +222.47% |
| LGVN | Longeveron Inc - Class A | 16.51 | +222.67% |
| ACOG | Alpha Cognition Inc | 16.80 | +228.33% |
| AXSM | Axsome Therapeutics Inc | 17.09 | +234.00% |
| PLUR | Pluri Inc | 17.50 | +242.02% |
| CANF | Can-Fite Biopharma Ltd | 17.56 | +243.19% |
| BEAM | Beam Therapeutics Inc | 17.79 | +247.68% |
| PRQR | ProQR Therapeutics N.V | 17.90 | +249.83% |
| IMNN | Imunon Inc | 17.94 | +250.61% |
| IPHA | Innate Pharma | 18.77 | +266.84% |
| ASND | Ascendis Pharma A/S | 20.12 | +293.22% |
| NRXS | Neuraxis Inc | 20.19 | +294.59% |
| EQ | Equillium Inc | 20.22 | +295.17% |
| LCTX | Lineage Cell Therapeutics Inc | 20.58 | +302.21% |
| VIVS | VivoSim Labs Inc | 20.99 | +310.22% |
| NTRB | Nutriband Inc | 21.11 | +312.57% |
| SEPN | Septerna Inc | 21.25 | +315.30% |
| PRLD | Prelude Therapeutics Inc | 21.25 | +315.30% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 21.98 | +329.57% |
| ZYME | Zymeworks BC Inc | 22.33 | +336.41% |
| CTMX | CytomX Therapeutics Inc | 22.42 | +338.17% |
| APM | Aptorum Group Limited Class A Ordinary Shares | 23.35 | +356.35% |
| UNCY | Unicycive Therapeutics Inc | 23.75 | +364.16% |
| KALA | Kala Bio Inc | 23.75 | +364.16% |
| IRD | Ocuphire Pharma Inc | 23.98 | +368.66% |
| IGC | IGC Pharma Inc | 24.19 | +372.76% |
| VIR | Vir Biotechnology Inc | 24.75 | +383.71% |
| BRTX | BioRestorative Therapies Inc | 24.97 | +388.01% |
| NBP | NovaBridge Biosciences. | 25.39 | +396.22% |
| KRYS | Krystal Biotech Inc | 25.84 | +405.01% |
| CGEM | Cullinan Oncology Inc | 25.86 | +405.40% |
| ABCL | AbCellera Biologics Inc | 25.99 | +407.94% |
| RNXT | RenovoRx Inc | 26.04 | +408.92% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 26.45 | +416.93% |
| DARE | Dare Bioscience Inc | 26.79 | +423.58% |
| SLS | SELLAS Life Sciences Group Inc | 26.90 | +425.73% |
| ABVC | ABVC BioPharma Inc | 27.42 | +435.89% |
| ABEO | Abeona Therapeutics Inc | 27.67 | +440.78% |
| BBIO | BridgeBio Pharma Inc | 27.92 | +445.66% |
| NTLA | Intellia Therapeutics Inc | 28.12 | +449.57% |
| ARMP | Armata Pharmaceuticals Inc | 28.16 | +450.35% |
| INSM | Insmed Inc | 28.42 | +455.43% |
| RANI | Rani Therapeutics Holdings Inc Class A | 29.37 | +474.00% |
| VRDN | Viridian Therapeutics Inc | 29.68 | +480.06% |
| WHWK | Whitehawk Therapeutics Inc | 30.04 | +487.09% |
| ADAG | Adagene Inc | 31.61 | +517.78% |
| MESO | Mesoblast Ltd | 33.10 | +546.90% |
| SRZN | Surrozen Inc | 33.76 | +559.80% |
| RYTM | Rhythm Pharmaceuticals Inc | 34.39 | +572.11% |
| IMTX | Immatics N.V | 34.70 | +578.17% |
| MTNB | Matinas Biopharma Holdings Inc | 34.81 | +580.32% |
| AGIO | Agios Pharmaceuticals Inc | 35.95 | +602.60% |
| CBIO | N/A | 36.36 | +610.61% |
| TOVX | Theriva Biologics Inc | 37.16 | +626.25% |
| CBUS | Cibus Global Ltd. Class A | 39.30 | +668.07% |
| XFOR | X4 Pharmaceuticals Inc | 40.81 | +697.58% |
| OCUL | Ocular Therapeutix Inc | 40.81 | +697.58% |
| NKTR | Nektar Therapeutics | 41.48 | +710.67% |
| KTTA | Pasithea Therapeutics Corp | 42.15 | +723.77% |
| EVMN | Evommune Inc | 44.84 | +776.34% |
| MCRB | Seres Therapeutics Inc | 45.04 | +780.25% |
| BYSI | BeyondSpring Inc | 45.99 | +798.82% |
| GLUE | Monte Rosa Therapeutics Inc | 46.04 | +799.79% |
| TRDA | Entrada Therapeutics Inc | 47.22 | +822.86% |
| PHIO | Phio Pharmaceuticals Corp | 48.01 | +838.29% |
| KRRO | Korro Bio Inc | 48.91 | +855.88% |
| SPRB | Spruce Biosciences Inc | 49.19 | +861.36% |
| CLDI | Calidi Biotherapeutics Inc | 50.83 | +893.41% |
| PPBT | Purple Biotech Ltd | 51.90 | +914.28% |
| SGMT | Sagimet Biosciences Inc - Class A | 52.50 | +926.05% |
| ALLR | Allarity Therapeutics Inc | 53.04 | +936.60% |
| KZIA | Kazia Therapeutics Ltd | 53.44 | +944.43% |
| FATE | Fate Therapeutics Inc | 55.18 | +978.42% |
| CAMP | CAMP4 Therapeutics Corp | 55.57 | +986.05% |
| VYNE | VYNE Therapeutics Inc | 55.68 | +988.20% |
| PGEN | Precigen Inc | 57.77 | +1029.04% |
| IBRX | ImmunityBio Inc | 57.87 | +1031.00% |
| STOK | Stoke Therapeutics Inc | 58.07 | +1034.90% |
| COCP | Cocrystal Pharma Inc | 58.22 | +1037.84% |
| ONCY | Oncolytics Biotech Inc | 58.60 | +1045.26% |
| PRTC | PureTech Health plc American Depositary Shares | 59.84 | +1069.50% |
| GLMD | Galmed Pharmaceuticals Ltd | 61.38 | +1099.59% |
| NBTX | Nanobiotix | 62.26 | +1116.79% |
| OVID | Ovid Therapeutics Inc | 64.47 | +1159.98% |
| ACIU | AC Immune SA | 65.70 | +1184.02% |
| EPIX | Essa Pharma Inc | 65.79 | +1185.74% |
| DMAC | DiaMedica Therapeutics Inc | 66.68 | +1203.18% |
| NRIX | Nurix Therapeutics Inc | 67.32 | +1215.68% |
| JANX | Janux Therapeutics Inc | 71.18 | +1291.12% |
| ADXN | Addex Therapeutics Ltd | 71.50 | +1297.38% |
| APRE | Aprea Therapeutics Inc | 73.15 | +1329.62% |
| IVA | Inventiva | 73.66 | +1339.59% |
| LEXX | Lexaria Bioscience Corp | 75.14 | +1368.52% |
| SILO | SILO Pharma Inc | 76.31 | +1391.38% |
| OMER | Omeros Corporation | 76.82 | +1401.35% |
| MAZE | Maze Therapeutics Inc | 81.33 | +1489.49% |
| NRXP | NRX Pharmaceuticals Inc | 83.25 | +1527.02% |
| IMA | Ikena Oncology Inc | 83.32 | +1528.38% |
| TNGX | Tango Therapeutics Inc | 86.42 | +1588.97% |
| ORMP | Oramed Pharmaceuticals Inc | 86.55 | +1591.51% |
| MIST | Milestone Pharmaceuticals Inc | 88.63 | +1632.16% |
| OGEN | Oragenics Inc | 89.28 | +1644.86% |
| ACRS | Aclaris Therapeutics Inc | 89.47 | +1648.58% |
| HUMA | Humacyte Inc | 90.61 | +1670.86% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 91.86 | +1695.29% |
| CVM | Cel-Sci Corp | 92.88 | +1715.22% |
| ADVM | Adverum Biotechnologies Inc | 94.37 | +1744.34% |
| RAPP | Rapport Therapeutics Inc | 95.49 | +1766.23% |
| AEON | AEON Biopharma Inc - Class A | 97.16 | +1798.87% |
| HIND | ReShape Lifesciences Inc | 104.32 | +1938.80% |
| MREO | Mereo Biopharma Group Plc | 104.68 | +1945.84% |
| CYTK | Cytokinetics Inc | 105.12 | +1954.44% |
| OCGN | Ocugen Inc | 108.42 | +2018.93% |
| RLYB | Rallybio Corp | 109.04 | +2031.05% |
| AIM | AIM ImmunoTech Inc. | 112.05 | +2089.88% |
| MNOV | Medicinova Inc | 113.02 | +2108.83% |
| PTGX | Protagonist Therapeutics Inc | 113.99 | +2127.79% |
| SKYE | Skye Bioscience Inc | 117.90 | +2204.21% |
| UPB | Upstream Bio Inc | 119.09 | +2227.46% |
| GRDX | Entero Therapeutics Inc | 119.29 | +2231.37% |
| ZBIO | Zenas Biopharma Inc | 119.50 | +2235.48% |
| CAPR | Capricor Therapeutics Inc | 124.43 | +2331.83% |
| RNAC | Cartesian Therapeutics Inc | 142.69 | +2688.70% |
| OPT | Opthea Ltd | 151.40 | +2858.85% |
| EYPT | EyePoint Pharmaceuticals Inc | 152.51 | +2880.62% |
| DBVT | DBV Technologies | 153.33 | +2896.64% |
| PRME | Prime Medicine Inc | 156.26 | +2953.90% |
| MOLN | Molecular Partners AG | 156.56 | +2959.77% |
| QURE | uniQure N.V. | 157.78 | +2983.61% |
| NAMS | NewAmsterdam Pharma Company NV | 165.68 | +3138.01% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 169.88 | +3220.09% |
| CRDF | Cardiff Oncology Inc | 175.81 | +3335.98% |
| KYMR | Kymera Therapeutics Inc | 182.36 | +3464.00% |
| GRCE | Acasti Pharma Inc | 197.75 | +3764.77% |
| LSTA | Lisata Therapeutics Inc | 200.88 | +3825.95% |
| GTBP | GT Biopharma Inc | 204.96 | +3905.68% |
| JUNS | Jupiter Neurosciences Inc | 212.82 | +4059.30% |
| SER | AgeX Therapeutics Inc | 224.96 | +4296.56% |
| ASBP | Aspire Biopharma Holdings Inc | 226.40 | +4324.70% |
| TSHA | Taysha Gene Therapies Inc | 238.09 | +4553.17% |
| AZTR | Azitra Inc | 239.97 | +4589.91% |
| GANX | Gain Therapeutics Inc | 255.50 | +4893.42% |
| CMPX | Compass Therapeutics Inc | 269.28 | +5162.74% |
| ATYR | Atyr Pharma Inc | 275.73 | +5288.79% |
| CYBN | Cybin Inc | 278.25 | +5338.04% |
| IBIO | iBio Inc | 279.86 | +5369.51% |
| YDES | YD Bio Ltd | 315.05 | +6057.25% |
| CDIO | Cardio Diagnostics Holdings Inc | 319.80 | +6150.09% |
| ATNM | Actinium Pharmaceuticals Inc | 320.69 | +6167.48% |
| CLRB | Cellectar Biosciences Inc | 348.47 | +6710.41% |
| VRNA | Verona Pharma Plc | 350.73 | +6754.58% |
| AUTL | Autolus Therapeutics plc | 372.63 | +7182.58% |
| ANIX | Anixa Biosciences Inc | 377.78 | +7283.23% |
| RLAY | Relay Therapeutics Inc | 398.28 | +7683.88% |
| TENX | Tenax Therapeutics Inc | 414.72 | +8005.18% |
| CADL | Candel Therapeutics Inc | 436.42 | +8429.28% |
| ALMS | Alumis Inc | 437.16 | +8443.74% |
| LXEO | Lexeo Therapeutics Inc | 478.26 | +9246.99% |
| CRNX | Crinetics Pharmaceuticals Inc | 491.45 | +9504.77% |
| ABOS | Acumen Pharmaceuticals Inc | 538.78 | +10429.77% |
| TVRD | Cara Therapeutics Inc | 559.61 | +10836.87% |
| IMRX | Immuneering Corp Class A | 563.62 | +10915.24% |
| ATAI | ATAI Life Sciences N.V. | 565.76 | +10957.06% |
| NGNE | Neoleukin Therapeutics Inc | 583.60 | +11305.72% |
| SLN | Silence Therapeutics Plc | 588.32 | +11397.97% |
| STTK | Shattuck Labs Inc | 608.39 | +11790.21% |
| LNAI | Lunai Bioworks Inc | 645.16 | +12508.84% |
| IMNM | Immunome Inc | 646.50 | +12535.03% |
| SYRE | Spyre Therapeutics Inc | 650.22 | +12607.73% |
| CNTB | Connect Biopharma Holdings Ltd | 656.66 | +12733.59% |
| OTLK | Outlook Therapeutics Inc | 695.79 | +13498.34% |
| OCS | Oculis Holding AG | 705.51 | +13688.30% |
| XENE | Xenon Pharmaceuticals Inc | 727.44 | +14116.90% |
| GRCL | Gracell Biotechnologies Inc | 732.21 | +14210.12% |
| INMB | INmune Bio Inc | 760.34 | +14759.88% |
| VRAX | Virax Biolabs Group Ltd - Class A | 793.06 | +15399.36% |
| TNYA | Tenaya Therapeutics Inc | 813.22 | +15793.36% |
| SNTI | Senti Biosciences Inc | 852.38 | +16558.69% |
| COGT | Cogent Biosciences Inc | 861.15 | +16730.09% |
| PROK | ProKidney Corp - Class A | 876.39 | +17027.93% |
| ABSI | Absci Corp | 900.52 | +17499.53% |
| PRAX | Praxis Precision Medicines Inc | 953.14 | +18527.92% |
| INBX | Inhibrx Biosciences Inc | 1029.47 | +20019.69% |
| CELZ | Creative Medical Technology Holdings Inc | 1195.26 | +23259.85% |
| CRSP | CRISPR Therapeutics AG | 1211.19 | +23571.18% |
| IBO | Impact BioMedical Inc | 1260.68 | +24538.40% |
| CGON | Cg Oncology Inc | 1269.73 | +24715.27% |
| ERNA | Ernexa Therapeutics Inc | 1275.37 | +24825.49% |
| PCSA | Processa Pharmaceuticals Inc | 1320.06 | +25698.90% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1459.05 | +28415.29% |
| ENTX | Entera Bio Ltd | 1547.08 | +30135.72% |
| TCRT | Alaunos Therapeutics Inc | 1689.15 | +32912.30% |
| INO | Inovio Pharmaceuticals Inc | 1712.37 | +33366.11% |
| ATOS | Atossa Therapeutics Inc | 1872.06 | +36487.05% |
| MBIO | Mustang Bio Inc | 2205.73 | +43008.20% |
| ABVX | Abivax | 2425.97 | +47312.52% |
| PULM | Pulmatrix Inc | 2459.21 | +47962.15% |
| BCDA | BioCardia Inc | 2520.59 | +49161.75% |
| BNTC | Benitec Biopharma Inc | 2770.13 | +54038.69% |
| ROIV | Roivant Sciences Ltd | 3008.13 | +58690.10% |
| PLRX | Pliant Therapeutics Inc | 3071.82 | +59934.84% |
| CLDX | Celldex Therapeutics Inc | 3476.34 | +67840.67% |
| NTHI | NeOnc Technologies Holdings Inc | 3477.63 | +67865.88% |
| KYTX | Kyverna Therapeutics Inc | 3513.34 | +68563.79% |
| CMRX | Chimerix Inc | 3613.35 | +70518.35% |
| DNLI | Denali Therapeutics Inc | 3643.65 | +71110.53% |
| SMMT | Summit Therapeutics Inc | 3891.31 | +75950.73% |
| PMN | ProMIS Neurosciences Inc | 4016.22 | +78391.94% |
| DNTH | Dianthus Therapeutics Inc | 4088.10 | +79796.75% |
| ALXO | Alx Oncology Holdings Inc | 5085.96 | +99298.66% |
| IFRX | InflaRx N.V. | 6161.81 | +120324.79% |
| GUTS | Fractyl Health Inc | 7575.74 | +147958.26% |
| ALLO | Allogene Therapeutics Inc | 7784.36 | +152035.48% |
| LPTX | Leap Therapeutics Inc | 8475.88 | +165550.30% |
| RLMD | Relmada Therapeutics Inc | 9001.90 | +175830.76% |
| RVMD | Revolution Medicines Inc | 9035.10 | +176479.61% |
| AVTX | Avalo Therapeutics Inc | 9875.25 | +192899.28% |
| ALT | Altimmune Inc | 10694.01 | +208900.91% |
| LYEL | Lyell Immunopharma Inc | 11272.00 | +220196.99% |
| PMCB | PharmaCyte Biotech Inc | 12904.41 | +252100.38% |
| GNLX | Genelux Corp | 16310.70 | +318672.01% |
| VTVT | vTv Therapeutics Inc - Class A | 17944.71 | +350606.67% |
| DSGN | Design Therapeutics Inc | 29402.82 | +574540.95% |
| TRML | Tourmaline Bio Inc | 30893.12 | +603667.03% |
| TIL | Instil Bio Inc | 54248.82 | +1060124.61% |
| ETNB | 89bio Inc | 111568.68 | +2180368.75% |
| EDSA | Edesa Biotech Inc | 130462.29 | +2549620.54% |
| SVRA | Savara Inc | 145272.62 | +2839069.72% |
| AKTX | Akari Therapeutics Plc | 478368.50 | +9349007.62% |
| NKTX | Nkarta Inc | 1.00M | +19543635.89% |